本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

14.91
-0.5900-3.81%
成交量:46.21万
成交额:694.25万
市值:21.80亿
市盈率:-5.31
高:15.62
开:15.52
低:14.78
收:15.50
52周最高:33.33
52周最低:10.57
股本:1.46亿
流通股本:1.32亿
量比:0.48
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-2.8082
每股收益(LYR):-2.5705
净资产收益率:-39.69%
总资产收益率:-24.99%
市净率:2.12
市盈率(LYR):-5.80

数据加载中...

2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities